Back to SUPN overview

SUPN Supernus Pharmaceuticals PE ratio, current and historical analysis

The current P/E ratio for Supernus Pharmaceuticals stock as of Feb 23, 2024 is 61.83. This is calculated based on the TTM EPS of $0.47 and the stock price of $29.06 per share. The PE ratio has increased by 49% from its last 4 quarters average of 41.5.

SUPN PE ratio history

How has SUPN's PE ratio performed in the past

The average historical PE ratio of Supernus Pharmaceuticals for the last nine years is 32.2. The current price-to-earnings ratio of 61.83 is 92% more than the historical average. Analyzing the last nine years, SUPN's PE ratio reached its highest point in the Jun 2015 quarter at 169.8, when the price was $16.98 and the EPS was $0.1. The lowest point was recorded in the Mar 2020 quarter, when it reached 8.14 with a price of $17.99 and an EPS of $2.21.

Average
32.2
Median
26.36
Minimum
8.14
Maximum
169.8

Supernus Pharmaceuticals PE ratio by year

Maximum annual increase: 176.53% in 2021

Maximum annual decrease: -70.39% in 2016

Year PE ratio Change
2022 31.57 9.35%
2021 28.87 176.53%
2020 10.44 -4.92%
2019 10.98 -29.62%
2018 15.6 -55.77%
2017 35.27 157.07%
2016 13.72 -70.39%
2015 46.34 N/A
2014 N/A N/A
2013 N/A N/A

SUPN average PE ratio chart

What is the average PE ratio of SUPN for the past years

The current PE ratio of SUPN is above its 3, 5 and 10-year averages.

3-year avg
30.74
5-year avg
22.88
10-year avg
32.2
15-year avg
N/A

SUPN PE vs peers

What is SUPN's PE ratio compared to its peers

SUPN's PE ratio is less than its peer stock LLY, but it is above JNJ's and ABT's. Supernus Pharmaceuticals's current PE ratio of 61.83 is in line with the average of its peers, which is 18.05.

Stock name PE ratio Market cap
UTHR UNITED THERAPEUTICS Corp 10.56 $10.46B
JNJ Johnson & Johnson 11.58 $387.06B
BMY Bristol Myers Squibb Co 13.11 $102.85B
ABT Abbott Laboratories 36.12 $205.59B
SUPN Supernus Pharmaceuticals Inc 62.94 $1.62B
LLY ELI LILLY & Co 132.64 $733.48B

Frequently asked questions

What is Supernus Pharmaceuticals's PE ratio?

The price to earnings ratio for SUPN stock as of Feb 23, 2024, stands at 61.83.

What is the 3-year average PE ratio for Supernus Pharmaceuticals (SUPN)?

Over the last 3 years, the average PE ratio for SUPN stock is 30.74.

What is the 5-year average PE ratio for Supernus Pharmaceuticals (SUPN)?

Over the last 5 years, the average PE ratio for SUPN stock is 22.88.

What is the highest PE ratio for SUPN?

The highest quarterly PE ratio in the last nine years has been 169.8 and it was in the Jun 2015 quarter.

How does the current PE ratio for SUPN compare to its historical average?

The current PE ratio of SUPN is 92% higher than the 9-year historical average.

How is SUPN's PE ratio calculated (Supernus Pharmaceuticals PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Feb 23, 2024), Supernus Pharmaceuticals's share price is $29.06. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2023 is $0.47. Therefore, Supernus Pharmaceuticals's price to earnings ratio for today is 61.83. PE RATIO(61.83) = STOCK PRICE($29.06) / TTM EPS($0.47)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.